Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?
Utility of Mathematically Converted Venous to Arterial Blood Gas for Clinical Monitoring
1 other identifier
observational
50
1 country
1
Brief Summary
Objective: Arterial blood gas (ABG) is essential in the clinical assessment of potential acutely ill patients venous to arterial conversion (v-TAC), a mathematical method, has recently been developed to convert peripheral venous blood gas (VBG) values to arterialized VBG (aVBG) values. The aim of this study is to test the reliability of aVBG compared to ABG in an intensive care unit (ICU) setting. Method: Consecutive patients admitted to the ICU with pH values \<7,35 or \>7,45 are included in this study. Paired ABG and aVBG samples are drawn from patients via arterial catheter, central venous catheter and/or peripheral venous catheter and compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2017
CompletedStudy Start
First participant enrolled
October 9, 2017
CompletedFirst Posted
Study publicly available on registry
October 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2018
CompletedOctober 13, 2017
October 1, 2017
4 months
October 4, 2017
October 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Lin's Concordance correlation coefficient (CCC)
Comparison of pH between ABG and aVBG (from peripheral venous catheter). The closer CCC is to 1 the better correlation.
1. january 2018
Lin's Concordance correlation coefficient (CCC)
Comparison of pCO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from peripheral venous catheter). The closer CCC is to 1 the better correlation.
1. january 2018
Lin's Concordance correlation coefficient (CCC)
Comparison of pO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from peripheral venous catheter). The closer CCC is to 1 the better correlation.
1. january 2018
Lin's Concordance correlation coefficient (CCC)
Comparison of pH between ABG and aVBG (from central venous catheter). The closer CCC is to 1 the better correlation.
1. january 2018
Lin's Concordance correlation coefficient (CCC)
Comparison of pCO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from central venous catheter). The closer CCC is to 1 the better correlation.
1. january 2018
Lin's Concordance correlation coefficient (CCC)
Comparison of pO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from central venous catheter). The closer CCC is to 1 the better correlation.
1. january 2018
Bland and Altman's plot
Mean difference and 95% limits-of-agreement of pH between ABG and aVBG (from peripheral venous catheter)
1. january 2018
Bland and Altman's plot
Mean difference and 95% limits-of-agreement of pCO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from peripheral venous catheter).
1. january 2018
Bland and Altman's plot
Mean difference and 95% limits-of-agreement of pO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from peripheral venous catheter).
1. january 2018
Bland and Altman's plot
Mean difference and 95% limits-of-agreement of pH between ABG and aVBG (from central venous catheter).
1. january 2018
Bland and Altman's plot
Mean difference and 95% limits-of-agreement of pCO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from central venous catheter).
1. january 2018
Bland and Altman's plot
Mean difference and 95% limits-of-agreement of pO2 (Unit of Measurement: kilopascal) between ABG and aVBG (from central venous catheter).
1. january 2018
Secondary Outcomes (6)
Number of patients with sepsis group.
1. january 2018
Number of patient with metabolic disease
1. january 2018
Number of patient with acute respiratory insufficiency
1. january 2018
Mean number of days until pH neutrality in sepsis group
1. january 2018
Mean number of days until pH neutrality in patients with metabolic disease.
1. january 2018
- +1 more secondary outcomes
Study Arms (3)
Respiratory disease
Patients with acute respiratory insufficiency admitted to the ICU and with pH \<7,35 or \>7,45
Metabolic disease
Patients with acute metabolic disease admitted to the ICU and with pH \<7,35 or \>7,45
Sepsis
Patients with acute sepsis admitted to the ICU and with pH \<7,35 or \>7,45
Interventions
Venous to arterial conversion (v-TAC) is a software (Obimedical, Denmark), which can convert venous blood gas values to arterial blood gas values. The principle of the method is a mathematical transformation of VBG values to arterialized values (aVBG) by simulating the transport of blood back through the tissue. To facilitate this simulation the following physiologically relevant assumptions were made: 1) The peripheral extremity was well perfused; 2) change in base excess across the tissue sampling site was approximately zero; 3) the respiratory quotient (rate of CO2 production and O2 utilisation over capillaries) could not vary outside the range 0.7 and 1.0, and 4) the haemoglobin concentration was constant from artery to vein.
Eligibility Criteria
All patients admitted to the ICU with acid-base and oxygenation parameters outside the normal reference values.
You may qualify if:
- All patients admitted to the intensive care with the following:
- Arterial catheter for other purpose.
- Peripheral venous catheter or central venous catheter for other purpose.
You may not qualify if:
- Normal pH in arterial blood gas.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aalborg Universitylead
- Regionshospital Nordjyllandcollaborator
Study Sites (1)
Faculty of Medicine, Doctoral School, Ph.d. study
Aalborg, North Denmark, 9000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Peter Leutscher
Professor, Center for Clinical Research
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 4, 2017
First Posted
October 13, 2017
Study Start
October 9, 2017
Primary Completion
January 30, 2018
Study Completion
March 30, 2018
Last Updated
October 13, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share
IPD will be stored in safe government controlled data drives and paper data will be stored in a secure office. Doors to this office will be closed when investigators are not present. Sensitive IPD will not be shared with external researchers.